Page results
-
UCLH is to trial a COVID-19 vaccine developed by Imperial College London.
-
Research published in the latest issue of the Journal of Medical Genetics concludes that regularly monitoring women who carry BRCA gene alterations does provide some benefits.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
UCLH will play a vital role in a new respiratory virus study.
-
Today is the 72 anniversary of the NHS – and it is dedicated to our amazing staff.
-
UCLH is to host to a new collaboration researching patient safety, after being awarded £3million in funding.
-
It’s a clean sweep for our nominees at this year’s RCN Nursing Awards. Congratulations to winners Jo Hargroves, Robert Vicente and Susie Lagrata!
-
UCLH will be part of a first-of-its kind clinical trial, led by scientists at UCL, that will evaluate the use of ‘real time’ viral genomic data to reduce the spread of COVID-19 within hospitals.
-
UCLH chair Baroness Julia Neuberger has today announced that Professor Marcel Levi will be stepping down from his role as UCLH chief executive on 31 March 2021.
-
As a mark of respect for the funeral of Her Majesty The Queen on Monday 19 September, we are postponing our Annual Members’ Meeting, which was scheduled for this date.
File results
-
FOI/2023/0203 - Maintenance contract(s) for flexible endoscope inventory
-
FOI/2023/0210 - Top five drugs that expired by value
-
FOI/2023/0211 - Services available to older residents
-
FOI/2023/0212 - Training provided to clinical staff for use of medical devices
-
FOI/2023/0222 - Contact details for senior screening and immunisations staff
-
FOI/2023/0231 - Patients seen at A&E with symptoms of taking nitrous oxide gas
-
FOI/2023/0237 - Software solution to manage patient e-consent for school vaccinations/ immunisations and waitlist validation
-
FOI/2023/0250 - Early Access to Medicines Scheme (EAMS)
-
FOI/2023/0251 - Vials used for immunoglobulin drugs - January to March 2023
-
FOI/2023/0332 - Eating disorder services and Advance Decisions/ Directives to refuse medical treatment (ADRTs)